|
Multidisciplinary Research focused on Parkinson's Disease, also known as MultiPark, is a strategic research area funded by the Swedish Government.〔http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html〕 The MultiPark project aims to improve life for patients suffering from Parkinson's disease. MultiPark represents a broad-ranging multidisciplinary mobilization where neuroscientists collaborate with researchers from chemistry, nanotechnology, physics and computer science. This hybrid of experimental and clinical science is intended to improve the quality of life for Parkinson patients. The MultiPark programme is translational, meaning that it ranges from pre-clinical research to studies on the everyday life situations of Parkinson's patients.〔http://www.ssfn.se/lu-links/multidisciplinary-research-focused-on-parkinsons-disease-mul.html〕 The programme aims to improve the patients' body functions but also their activity and participation. The initiative relies on interactions between Lund University and Skane University Hospital with support from the University of Gothenburg. Several drugs are currently available for Parkinson's disease, but their beneficial effects often diminish with time. The scientists involved in MultiPark aim to improve different treatments' ability to slow, or stop, the course of the disease. == Related Research Environments == Bagadilico () CASE () NeuroFortis () Neuronano Research Center () Swedish Parkinson Academy (5 ) 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「MultiPark」の詳細全文を読む スポンサード リンク
|